Portable ultrasound

FUJIFILM Sonosite Introduces Sonosite Voice Assist, a Groundbreaking Voice Command Feature for Point of Care Ultrasound

Retrieved on: 
Thursday, February 1, 2024
POCUS, Health, Human voice, System, Portable ultrasound, Human, Nursing

The Voice Assist is easily activated with a simple voice command, “Activate Voice,” whereby proceduralists are immediately able to control many of the critical functions hands-free during an exam.

Key Points: 
  • The Voice Assist is easily activated with a simple voice command, “Activate Voice,” whereby proceduralists are immediately able to control many of the critical functions hands-free during an exam.
  • FUJIFILM Sonosite’s Voice Assist feature allows users to freeze and save images, adjust gain settings, and add color flow all through the proceduralists voice command.
  • Additionally, the hands-free operation allows the proceduralist to stay fully focused on the patient, contributing to a safer, more sterile environment.
  • “This groundbreaking advancement demonstrates FUJIFILM Sonosite’s commitment to not only enhancing its products but also improving patient care and empowering healthcare professionals to deliver the best possible medical services," said Rich Fabian, chief executive officer and president of FUJIFILM Sonosite.

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

Retrieved on: 
Wednesday, December 13, 2023
AdvaMed, Portable ultrasound, Wound healing, Regenerative medicine, Smith, Amputation, Face, Wound, Growth, OTC, Covidien, MITA, Management

(OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.

Key Points: 
  • (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.
  • Mr. Dugan brings a wealth of experience to BioStem, with proven, hands-on expertise as a senior executive who has transformed businesses, established new market opportunities, and driven growth in the face of strong competition.
  • BioStem Technologies CEO, Jason Matuszewski, said, “I am delighted to welcome Mr. Dugan to BioStem’s Board of Directors.
  • Mr. Dugan served on the board of directors of Rita Medical Systems (NASDAQ: RITA), which was acquired by AngioDynamics, and various venture-backed medical device companies.

SONEX HEALTH HOSTS FIRST-EVER FORUM FOR SURGEONS TO EXPLORE AND SHAPE THE FUTURE OF MSK ULTRASOUND IN HAND SURGERY

Retrieved on: 
Tuesday, September 26, 2023
GE HealthCare, Bone, Surgeon, University, University of Pittsburgh School of Dental Medicine, Education, Thomas Jefferson University, Health, GE, Research, ASSH, Sonex Aircraft, Konica Minolta, Integration, Westin Harbour Castle Hotel, Physician, Clarius, Orthopedic surgery, MSK, Human musculoskeletal system, Portable ultrasound, Society, Medical device

EAGAN, Minn., Sept. 26, 2023 /PRNewswire/ -- Sonex Health and the Institute of Advanced Ultrasound Guided Procedures have announced they are hosting the first annual Musculoskeletal (MSK) Ultrasound Forum, bringing surgeons together to exchange ideas, engage in hands-on learning activities, and shape the future of MSK ultrasound in hand surgery. This first-ever forum on Oct. 3 from 4 to 10 p.m. at the Westin Harbour Castle precedes the American Society for Surgery of the Hand (ASSH) 2023 Annual Meeting in Toronto Oct. 5-7.

Key Points: 
  • EAGAN, Minn., Sept. 26, 2023 /PRNewswire/ -- Sonex Health and the Institute of Advanced Ultrasound Guided Procedures have announced they are hosting the first annual Musculoskeletal (MSK) Ultrasound Forum, bringing surgeons together to exchange ideas, engage in hands-on learning activities, and shape the future of MSK ultrasound in hand surgery.
  • "We're excited to bring together thought leaders to educate, discuss and explore the future of MSK ultrasound in this first event of its kind," said Dr. John R. Fowler, MSK Ultrasound Forum event chair, associate professor and assistant dean for medical student research, University of Pittsburgh's Department of Orthopaedic Surgery.
  • "Partnering with Sonex Health and a renowned executive committee of physicians, this annual meeting focuses on innovation, and we welcome surgeons to join us in physician-led discussions, education and exchange of ideas in shaping the future of MSK ultrasound."
  • The forum brings together more than 75 hand surgeons to advance MSK ultrasound through innovation, education and training.

FUJIFILM Sonosite Introduces the All-Touchscreen Sonosite ST POCUS System, Designed and Engineered to Support Procedural Workflows

Retrieved on: 
Tuesday, September 12, 2023
Transducer, Emergency medicine, Workflow, POCUS, Hospital, SNP, Disinfectant, System, Portable ultrasound, Medical imaging

Bothell, WA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the launch of the Sonosite ST.

Key Points: 
  • Bothell, WA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the launch of the Sonosite ST.
  • Sonosite ST also shares the same family of transducers with Sonosite PX and Sonosite LX to support compatibility across systems.
  • 'I’m very confident the Sonosite ST will become an industry workhorse for procedure-focused clinicians,' Fabian added.
  • FUJIFILM Sonosite also provides an industry-leading five-year warranty, which reduces cost of ownership over time.

Longeveron Welcomes Three New Prominent Board Members

Retrieved on: 
Tuesday, June 13, 2023
Bachelor of Science in Human Biology, FACC, University of Pennsylvania, MBA, City, University of London, Audible Magic, Thomas, Eli Lilly and Company, Berlin Packaging, Joseph M. Katz Graduate School of Business, University, Galena Biopharma, Carnegie Mellon University, Regenerative medicine, Boehringer Ingelheim, UCB, Magic, Book, Biotechnology, S.A, Wharton School of the University of Pennsylvania, Cranfield School of Management, Amgen, PCSA, Girolamo, San Francisco Playhouse, Portable ultrasound, Organizational behavior, SONO, Postgraduate education, WSTM, Aerospace engineering, American University in Cairo, Strategic Advisory Board for Intellectual Property Policy, Management, MD, Shareholder, Stanford University

MIAMI, June 13, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, announced today the election of three distinguished new directors to serve on the Longeveron Inc. Board of Directors. Wa’el Hashad, Khoso Baluch, and Jeffrey Pfeffer were elected at the Company’s Annual Meeting of Stockholders, held Friday June 9, 2023, and will serve until the 2026 Annual Meeting of Stockholders, or until their successors are duly elected. Concurrent with the election of the new Directors, the terms of Donald Soffer, Erin Borger, and Todd Girolamo to serve as directors expired.

Key Points: 
  • “We are very honored to welcome such prominent and experienced new members to our Board and look forward to their tremendous expertise, diverse experience, and counsel as we continue to advance our regenerative medicine toward critical milestones,” said Joshua M. Hare, MD, FACC, and Chairman of Longeveron.
  • We believe Longeveron is well positioned to realize the potential of Lomecel-B™, and we thank them for their dedication and service,” concluded Dr. Hare.
  • Summary biographies of the new directors are as follows:
    Wa’el Hashad has served as Chief Executive Officer of Longeveron since February, 2023.
  • He served as the Chairman of the Board for Da Volterra, a French privately held company, from December 2021 until November 2022.

FUJIFILM Sonosite Introduces the All Touchscreen Sonosite ST POCUS System Designed and Engineered to Support Procedural Workflows

Retrieved on: 
Wednesday, May 31, 2023
Transducer, Emergency medicine, Workflow, POCUS, Anesthesia, Hospital, SNP, Disinfectant, System, Portable ultrasound, Medical imaging, Nursing

Bothell, WA, May 31, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the launch of Sonosite ST.

Key Points: 
  • Bothell, WA, May 31, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the launch of Sonosite ST.
  • Sonosite ST also shares the same family of transducers with Sonosite PX and Sonosite LX to support compatibility across systems.
  • “I’m very confident the Sonosite ST will become an industry workhorse for procedure-focused clinicians,” Fabian added.
  • FUJIFILM Sonosite also provides an industry leading five-year warranty, which reduces cost of ownership over time.

Report: Washington State’s $35B Life Science Industry Grows Amid Economic Downturn

Retrieved on: 
Tuesday, April 25, 2023
Professional Services, Science, Other Science, Research, Human Resources, Private sector, Pacific Ocean, Portable ultrasound, COVID-19, Woman, Organization, Machine learning, Economic impact analysis, City, Pharmaceutical industry

Life Science Washington , the state’s industry trade association, today released a new Economic Impact Report , revealing Washington state’s $35.3 billion life science industry supports more than 100,000 jobs throughout the state and continues to serve as a buffer during economic downturns.

Key Points: 
  • Life Science Washington , the state’s industry trade association, today released a new Economic Impact Report , revealing Washington state’s $35.3 billion life science industry supports more than 100,000 jobs throughout the state and continues to serve as a buffer during economic downturns.
  • “Washington’s life science industry continued to add jobs during the pandemic,” said Marc Cummings, President and CEO of Life Science Washington.
  • “The steady expansion of Washington’s life science industry shows companies’ dedication to tackling some of the toughest global health challenges through cutting-edge science,” said Richard Fabian, CEO of FUJIFILM SonoSite and Life Science Washington Board Chair.
  • Leaders in the Washington state life science industry will come together to discuss the report’s findings and latest innovation in the region at Life Science Innovation Northwest , the Pacific Northwest’s largest annual life science conference, on April 25-26.

Home Ultrasound Developer Pulsenmore Establishes European Operations and Appoints General Manager

Retrieved on: 
Wednesday, April 19, 2023
GE HealthCare, CE, Partnership, Pregnancy, GE, Samsung, Privacy, IVF, Patient, TASE, Health, Portable ultrasound, Medical imaging

RAMAT GAN, Israel, April 19, 2023 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a global leader in self-scan ultrasound devices for remote clinical diagnosis, has appointed Mr. Johannes Scheibl as General Manager Europe.

Key Points: 
  • RAMAT GAN, Israel, April 19, 2023 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a global leader in self-scan ultrasound devices for remote clinical diagnosis, has appointed Mr. Johannes Scheibl as General Manager Europe.
  • This expansion will be carried out concurrently with the ongoing partnership with GE HealthCare, which has invested in Pulsenmore and holds distribution rights for the company's home ultrasound devices.
  • His deep knowledge of the ultrasound industry in European markets makes him an asset, as the company establishes its presence in the region.
  • Pulsenmore's flagship product, Pulsenmore ES, is a CE-certified self-scan ultrasound for at-home use and remote clinical care, prescribed by clinicians and complementary to routine ultrasound exams.

ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS

Retrieved on: 
Wednesday, November 2, 2022
Marketing, RNA, Growth, Board of directors, CEO, Procter & Gamble, BBC, Doctor of Philosophy, Vector Security, General manager, Korn Ferry, Research, Board, BPS, Acceleration, NIH, Microalgae, Nasdaq, Industry, Medical device, Baxter, Health, Baxter International, Portable ultrasound, Microsoft, Technology, National, Drexel Burnham Lambert, Pulmonary hypertension, Compliance, Company, Noble gas, Severe acute respiratory syndrome coronavirus 2, Global, Pharmaceutical industry, Management, UW, Illumina

WOODINVILLE, Wash., Nov. 2, 2022 /PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing, recently announced the election of three new outside members to its Board of Directors, Bryan Crane, PhD, Arthur Kirsch, and David Vied.

Key Points: 
  • WOODINVILLE, Wash., Nov. 2, 2022 /PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing, recently announced the election of three new outside members to its Board of Directors , Bryan Crane, PhD, Arthur Kirsch, and David Vied.
  • "We are thankful to have these three talented individuals join the board,"said Nelson Patterson, President, and CEO of Anavasi Diagnostics.
  • Vied join a seasoned executive team of Board of Directors, led bythe President and CEO, Nelson Patterson.
  • Anavasi Diagnostics is a rapidly growing medical technology company focused on developing novel molecular diagnostic testing using a proprietary reverse transcriptase methodology (patent-pending).

FUJIFILM Sonosite announces the European launch of Sonosite LX, the industry leader’s latest premium point-of-care ultrasound system

Retrieved on: 
Monday, September 26, 2022
TEE, Workflow, Temperature, Time, Cardiac arrest, TEU, Resuscitation, Transducer, Arrest, LX, FACEP, MSCE, POCUS, FUJIFILM, Patient, Emergency medicine, CEO, Technology, Disinfectant, TOU, Solution, GLOBE, Union, Death, Medical imaging, MD, Portable ultrasound

Were thrilled to bring the Sonosite LX to Europe, building on the momentum of successful introductions in the U.S., Canada, Australia, and New Zealand.

Key Points: 
  • Were thrilled to bring the Sonosite LX to Europe, building on the momentum of successful introductions in the U.S., Canada, Australia, and New Zealand.
  • Sonosite LX has a large, adaptable 21.3 clinical display that extends, rotates and tilts to accommodate the varied clinical environments at the bedside.
  • As with all Sonosite point of care ultrasound systems, Sonosite LX is built to legendary durability, reliability, and ease of use standards.
  • The ultrasound transducers are drop-tested to one metre and the work surface is sealed to the edge for simplified cleaning and disinfection.